Nothing Special   »   [go: up one dir, main page]

AZOURY et al., 1966 - Google Patents

Intradermal tests and antinuclear factors in systemic lupus erythematosus: A comparative study

AZOURY et al., 1966

Document ID
7058200153657165269
Author
AZOURY F
JONES H
DERBES V
GUM O
Publication year
Publication venue
Annals of Internal Medicine

External Links

Snippet

Excerpt Abnormal immunological reactions have been described more frequently and in greater number in systemic lupus erythematosus (SLE) than in any other disease. A wide variety of circulating antibodies that are capable of reacting with the patient's own tissues …
Continue reading at www.acpjournals.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Pick et al. Interaction betweensensitized lymphocytes' and antigen in vitro: I. The release of a skin reactive factor
Corradin et al. Lymphocyte specificity to protein antigens: I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice
Joynson et al. Defect of cell-mediated immunity in patients with iron-deficiency anaemia
Sobotka et al. Allergy to insect stings: II. Phospholipase A: The major allergen in honeybee venom
Yodoi et al. Lymphocytes bearing Fc receptors for IgE. IV. Formation of IgE-binding factor by rat T lymphocytes.
Ward et al. Chemotaxis of rat lymphocytes
Knight et al. The transformation in vitro of peripheral lymphocytes of some laboratory animals
Clancy Cellular immunity to autologous platelets and serum-blocking factors in idiopathic thrombocytopenic purpura
Martin et al. Immunological alterations in patients with treated Whipple’s disease
AZOURY et al. Intradermal tests and antinuclear factors in systemic lupus erythematosus: A comparative study
Rozee et al. Effect of priming on interferon inhibition of Con A induced spleen cell blastogenesis
Baumal et al. Studies into the occurrence of soluble antigen–antibody complexes in disease. III. Rheumatoid arthritis and other human diseases
Sirianni et al. Protein A-positive staphylococci serve as a selective B cell mitogen for lymphocytes from primary immunodeficiency patients.
Rolfe et al. Identification of two suppressor factors induced by early pregnancy factor.
Wasserman et al. Antibody-induced in vitro lymphocyte cytotoxicity in Hashimoto thyroiditis
Jensen et al. Antigen specific lymphocyte activity in vitro by peripheral blood leucocytes from Mantoux positive and negative human beings. I. Comparison of quantitative and qualitative differences in the PPD-specific lymphoproliferative response of lymphocytes from the two kinds of donors.
Urban Jr et al. IgE-B Cell-Generating Factor from Lymph Node Cells of Rats Infected with Nippostrongylus Brasiliensis: I. Source of IgE-B Cell-Generating Factor
Bello-Rivero et al. Characterization of the immunoreactivity of anti-interferon alpha antibodies in myasthenia gravis patients. Epitope mapping
Clark et al. Mediator release from basophil granulocytes in chronic myelogenous leukemia: Demonstration of the eosinophil chemotactic activity of histamine
Jones et al. Skin tests with nuclear factors in systemic lupus erythematosus
Hall et al. Lymphocytes bearing Fc gamma receptors in rheumatoid arthritis. I. An increased subpopulation of cells in rheumatoid arthritis detected with Facb rosettes.
Svec et al. A variant LE cell factor reactive only with “altered” nuclear material
Cohen et al. Activated T cells in human peripheral blood: quantitation with a reverse hemolytic plaque assay.
Levis et al. Clonal priming of human lymphocytes: Specificity and cross-reactivity of cellular immune reactions
Suzuki et al. Drug-induced lymphocyte transformation in peripheral lymphocytes from patients with drug eruptions: Possible involvement of carrier contained in cutaneous tissues